capecitabine has been researched along with Paraneoplastic Syndromes in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linares-Gonzalez, L; Ródenas-Herranz, T; Ruiz-Villaverde, R; Sánchez-Cano, D | 1 |
| de Weger, VA; Griffioen-Keijzer, A; van Bunderen, CC | 1 |
| Enk, AH; Gronau, M; Hassel, JC; Jäger, D | 1 |
| Coras, B; Hafner, C; Landthaler, M; Reichle, A; Vogt, T | 1 |
1 review(s) available for capecitabine and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Disseminated intravascular coagulation as clinical manifestation of colorectal cancer: a case report and review of the literature.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Deoxycytidine; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Oxaloacetates; Paraneoplastic Syndromes; Sigmoid Neoplasms | 2014 |
3 other study(ies) available for capecitabine and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Capecitabine-induced bilateral ectropion on a patient with paraneoplastic dermatomyositis.
Topics: Autoantibodies; Capecitabine; Dermatomyositis; Ectropion; Humans; Paraneoplastic Syndromes | 2020 |
Necrolytic migratory erythema in a patient with neuroendocrine carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Capecitabine; Carcinoma, Neuroendocrine; Dacarbazine; Deoxycytidine; Diagnosis, Differential; Drug Eruptions; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Necrolytic Migratory Erythema; Neoplasm Staging; Pancreatic Neoplasms; Paraneoplastic Syndromes; Risk Assessment; Temozolomide; Treatment Outcome | 2013 |
Antiangiogenic therapy in metastatic prostate carcinoma complicated by cutaneous lupus erythematodes.
Topics: Angiogenesis Inhibitors; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Capecitabine; Cyclophosphamide; Deoxycytidine; Drug Administration Schedule; Fluorouracil; Humans; Liver Neoplasms; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Paraneoplastic Syndromes; Pioglitazone; Prostatic Neoplasms; Thiazolidinediones | 2006 |